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Conclusions: The overall prevalence of coronary artery disease in a
study group of patients with rheumatic heart disease undergoing
valve surgery in western India in single centre is 12.2%. This
prevalence is much lower than the ﬁgures reported earlier in
the Western literature.
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Background: Degenerative aortic stenosis (DAS) and coronary
artery disease (CAD) share common risk factors. In some of the
previous studies statins have been used to retard the progression
of aortic stenosis, but the results are inconsistent
Objective (aim): To study the risk factor proﬁle in degenerative
aortic stenosis with and without associated CAD.
Methods: One hundred and ten patients of DAS above the age of
40 years have undergone clinical, biochemical and echocardio-
graphic evaluation. Coronary angiograms were done in 68% of
the cases.
Results: Male to female ratio is 2:1. Patients of DAS with CAD
showed higher prevalence of diabetes, hypertension, dyslipide-
mia, smoking and family history of CAD. Prevalence of obesity and
bicuspid aortic valve by echocardiogramwas high in those without
CAD.
Conclusion: Our observations are in agreement with those of Kora/
Monica and SEAS studies but the prevalence of diabetes is high in
our study. This is the ﬁrst Indian study to study the risk factor
proﬁles in cases of DAS.
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Severe MS is usually symptomatic and is treated by BMV or sur-
gery, whereas mild to moderate mitral stenosis is usually asymp-
tomatic or mildly symptomatic and managed medically. Patients
in the latter group may become symptomatic during episodes of
exercise and increased heart rate. As increase in heart rate occurs
mostly at the expense of diastole, there is shortening of the
diastolic ﬁlling period, and in the presence of obstruction at the
mitral valve this results in increased left atrial pressure. Subse-
quently, pulmonary capillary wedge pressure rises, resulting in
effort intolerance and dyspnea. Theoretically, negative chronotro-
pic agents such as blockers and CCBs should be helpful in con-
trolling tachycardia-related symptoms by improving diastolic
ﬁlling and preventing rise in pulmonary capillary wedge pressure.
However, associated negative inotropic effect on myocardium and
effect on neuromuscular system may negate the beneﬁcial effects
of these drugs. CCBs have little role in controlling heart rate when
the patient is in sinus rhythm. Results from various clinical and
hemodynamic studies with these agents have been conﬂicting.
We studied 97 patients of mitral stenosis in sinus rhythm pre-
sented with exertional symptoms. The effectiveness of metoprolol
is compared with ivabradin in alleviating these exertional symp-
toms in a randomized, open label non cross over study. We also
assessed various stress ECG parameters, 24 hr Holter parameters
and 2D echo parameters to objectively compare the effect of
ivabradin and metoprolol in these patients. The ﬁndings are as
follows:
 Ivabradin and metoprolol both are effective in controlling
exertional symptoms.
 Signiﬁcant improvement in objective parameters like TMT
(work capacity, baseline heart rate and maximum heart
rate), 24 hr Holter (minimum heart rate, average heart rate
and maximum heart rate) and 2D echocardiography (right
ventricular systolic pressure) are seen with both drugs.
 Ivabradin control the exertional symptoms signiﬁcantly
more than metoprolol.
 Objective parameters improve signiﬁcantly more with ivab-
radin than metoprolol except average heart rate reduction.
Conclusion: Ivabradin is better than metoprolol in medical man-
agement of mitral stenosis patients Ivabradin should be strongly
Table 2 – Distribution of valve lesions and coronary artery
disease.
Valve involved Total no.
of patients
(%) of patients
with CAD
Mitral valve 7 13.5
Aortic valve 62 15.3
Combined 7 9.0
Total 188 12.2
Table 3 – Reported prevalence of coronary artery disease
in mitral valve disease.
Author Year No. of patients
Reported
Studied
prevalence (%)
Befeler et al. 1970 26 50
Lacy et al. 1977 67 32
Baxter et al. 1978 82 22
Saltups 1982 100 23
Chun et al 1982 82 26
Czer et al. 1984 56 27
Mattina et al. 1986 96 28
CMC Vellore 2003 96 13.5
Table 4 – Reported prevalence of coronary artery disease
in aortic valve disease.
Author Year No. of patients
reported
Studied
prevalence (%)
Coleman & Soloff 1970 77 17.7
Harris et al. 1975 69 23.2
Baxter et al. 1978 47 17
Vandeplas et al. 1988 192 24
Ravi Kishore et al. 1988 106 5.6
CMC Vellore 2003 124 15.3
Saltups 1982 100 30
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considered in medical management of mitral stenosis patients
where b blockers are contra indicated such as reactive air way
disease. The coast of ivabradin is higher than metoprolol which
might poses constrains as most of rheumatic heart disease
patients belongs to low socioeconomic status.
Drawbacks of the study are small sample size and invasive para-
meters like PCWP which play major role in mitral stenosis has not
been assessed in the trial. Longer follow-up study is needed to
effectively comment on safety proﬁle of ivabradin.
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Introduction: Percutaneous mitral balloon valvotomy has proved
to be an effective method for the treatment of patients with mitral
valve stenosis with favourable short andmid-term results. In view
of the reduction of the left atrial pressure after successful percu-
taneous mitral balloon valvotomy, one would anticipate a lower
incidence of atrial ﬁbrillation (AF). However, in the past, several
studies of the cardiac rhythm after surgery for mitral valve disease
have shown that chronic AF persisted in the majority of patients
despite successful mitral valve repair or replacement, probably
because atrial electrical remodelling strongly contributes to per-
sistence of AF. Information on the short- or long-term course of
cardiac rhythm after percutaneous mitral balloon valvotomy
remains very limited.
Long-term follow-up studies demonstrated that the development
of AFmarkedly increased the risk of cardiovascular complications.
Moreover it is generally accepted that AF concomitant with rheu-
matic valve disease exhibits a considerably higher relative risk of
stroke than AF without valvular disease.
This study is designed to evaluation of atria by cardiac MRI in Post
Ballon Mitral Valvotomy rheaumatic mitral stenosis patients at
tertiary care hospital.
Aims and objectives: Evaluation of left atrial morphology by car-
diac MRI in Post percutaneous Ballon Mitral Valvotomy patients.
Materials & methods: This study was prospective having sample
size of 10 and sampling method was random with inclusion
criteria:
 Post BMV patients with rheumatic valvular disease.
 Hemodynamically stable patients.
 Patients between 12 and 40 yrs of age.
Exclusion criteria:
 Patients not consenting for the study.
 Patients with age <12 yrs.
 Patients with age >40 yrs.
 Patients with nonrheumatic valvular disease.
 Patient with any contraindications for MRI.
 Pregnancy (Risk vs beneﬁt ratio to be assessed).
 Known h/o contrast allergy.
Method: Patients with rheumatic mitral valve stenosis who have
undergone percutaneous Balloon Mitral Valve procedure and
satisfying inclusion and exclusion criteria will be included in the
study. Patients who were in sinus rhythm preoperatively will be
included in the control group while patients having atrial ﬁbrilla-
tion preoperatively will be included in cases group.
All the patients will undergo Cardiac MRI to detect the atrial size
and ﬁbrosis. MRI will be done on Philips achieva series 3T imager.
Patients with atrial ﬁbrillation will be ﬁrst given anticoagulation (if
LA clot is present) followed by cardioversion (DC shock or amio-
darone) and brought to sinus rhythm before doing MRI.
Results: Out of total 10 patients in our study 2 patients of atrial
ﬁbrillation had LA volume of >30 cm2 on cardiac MRI and total 8
patients in sinus rhythm had LA volume of <30 cm2. LA scar and
subendocardial enhancement was found in total 6 out of 10
patients in our study. However those patients who had atrial
ﬁbrillation (n = 2) had not demonstrated any LA morphological
abnormality.
Conclusion: LA volume rather than LAmorphological abnormality
is associated with atrial ﬁbrillation in post-percutaneous mitral
balloon valvotomy of rheumatic mitral stenosis. While atrial ﬁbril-
lation patients with no LA morphological abnormality associated
with more likely successful cardioversion and maintenance of
sinus rhythm in our short term study.
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Background: Moderate and severe tricuspid regurgitation (TR) in
patients with severe mitral stenosis may persist after successful
percutaneous mitral balloon valvotomy (PMV). Its clinical impor-
tance has been well established because its persistence may con-
tribute to a poor outcome after the procedure. This is a cohort study
over a three-year period of cases seen at our centre. The records of
patients with signiﬁcant TR before successful PMV were reviewed
in term of the resolution and its persistence immediately and long
after the procedure. Clinical outcome were also analysed in rela-
tion to signiﬁcant TR in terms of functional impairment, repeated
PMV,mitral surgery and death. Factors associatedwith persistence
of TR were also noted. Survival analysis was performed.
Methods and results: Seventy-nine patients were included in the
study. They were divided into two groups, those with insigniﬁcant
TR and those with signiﬁcant TR immediately after successful
PMV. Majority of the population were female with mean age of
33  8 and 32  9.5 respectively. Tricuspid regurgitation was
resolved to trace or mild in 42 (53%) patients and persisted in 37
(47%). On 3 year follow-up TR became insigniﬁcant in 15 (41%)
patients who initially had moderate to severe TR after PMV, while
22 (59%) continued to have signiﬁcant TR. Twelve (29%) patients
with initially had trace to mild TR after PMV developed signiﬁcant
TR. Patients with moderate to severe TR immediately and after
PMV and those who developed signiﬁcant TR on follow-up had
elevated PAP, TVA and RV diameter on the last follow-up. Presence
of organic TR was also signiﬁcantly associated with patients hav-
ing persistent signiﬁcant TR. There was a marked reduction of
symptoms in almost all of the patients after the procedure, and
majority remained remarkably stable on follow-up. However
patients with signiﬁcant TR on follow-up had higher rates of
functional impairment compared to those in whom TR resolved
to trace or mild. The event free survival rates for trace to mild TR
was 80% and 52% for those with moderate to severe TR.
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